InnoCare Pharma Limited
INCPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $40 | $39 | $33 | $37 |
| - Cash | $6 | $8 | $9 | $6 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $35 | $33 | $26 | $32 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 36.7% | 18.1% | -40% | – |
| Gross Profit | $1 | $1 | $0 | $1 |
| % Margin | 86.3% | 82.6% | 77.1% | 93.7% |
| EBITDA | -$0 | -$1 | -$1 | -$0 |
| % Margin | -31% | -69.9% | -129.2% | -16% |
| Net Income | -$0 | -$1 | -$1 | -$0 |
| % Margin | -43.7% | -85.5% | -141.8% | -6.2% |
| EPS Diluted | -0.26 | -0.37 | -0.6 | -0.037 |
| % Growth | 29.7% | 38.3% | -1,539.3% | – |
| Operating Cash Flow | -$0 | -$1 | -$1 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$1 | -$1 | -$0 |